COVID-19 lockdown reduced mental health, sleep, exercise

October 23, 2020

A first-of-its-kind global survey shows the initial phase of the COVID-19 lockdown dramatically altered our personal habits, largely for the worse.

"The stay-at-home orders did result in one major health positive. Overall, healthy eating increased because we ate out less frequently. However, we snacked more. We got less exercise. We went to bed later and slept more poorly. Our anxiety levels doubled," said Leanne Redman, PhD, Associate Executive Director for Scientific Education at Pennington Biomedical Research Center.

The global survey evaluated the inadvertent changes in health behaviors that took place under the pandemic's widespread restrictions. Researchers found that the lockdown's effects were magnified among people with obesity.

"Overall, people with obesity improved their diets the most. But they also experienced the sharpest declines in mental health and the highest incidence of weight gain," Dr. Redman said. "One-third of people with obesity gained weight during the lockdown, compared to 20.5 percent of people with normal weight or overweight."

The online survey study ran during the month of April. More than 12,000 people worldwide took a look at the survey and 7,754 completed the detailed online questionnaire. The majority of the respondents were in the United States, with half from Louisiana. Residents of Australia, Canada, the United Kingdom, and more than 50 other countries also responded.

Those who took the survey reacted to the pandemic in largely the same way whether they live in Louisiana, elsewhere in the United States or abroad.

"This study is the first to survey thousands of people across the globe on lifestyle behavior changes in response to stay-at-home orders. Groundbreaking research like this is part and parcel of Pennington Biomedical's mission. The study demonstrates that chronic diseases like obesity affect our health beyond the physical," said Executive Director John Kirwan, PhD. "Dr. Redman's study is just one of many initiatives the center launched to help understand COVID-19's impact and to slow its spread."

The research team would like physicians and scientists to modify the way they manage patients with obesity in two ways, said Emily Flanagan, PhD, lead author of the study and a postdoctoral researcher in Dr. Redman's Reproductive Endocrinology and Women's Health Laboratory.
-end-
The full results of the study are available here.

This work was partially supported by the Pennington/Louisiana Nutrition Obesity Research Center award DK072476 and the Louisiana Clinical and Translational Science Center award GM104940 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About the Pennington Biomedical Research Center

The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. The Center conducts basic, clinical, and population research, and is affiliated with Louisiana State University. The research enterprise at Pennington Biomedical includes over 450 employees within a network of 40 clinics and research laboratories, and 13 highly specialized core service facilities. Its scientists and physician/scientists are supported by research trainees, lab technicians, nurses, dietitians, and other support personnel. Pennington Biomedical is located in state-of-the-art research facilities on a 222-acre campus in Baton Rouge, Louisiana. For more information, see http://www.pbrc.edu.

Pennington Biomedical Research Center

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.